Mutual scrutiny and information exchange : uncovering R&D Partners’ impact on ESG performance in the biopharmaceutical industry
Yahan Hu, Qinqin Zheng
| Year of publication: |
2025
|
|---|---|
| Authors: | Hu, Yahan ; Zheng, Qinqin |
| Published in: |
Journal of business research : JBR. - New York, NY : Elsevier, ISSN 0148-2963, ZDB-ID 2013438-1. - Vol. 195.2025, Art.-No. 115408, p. 1-17
|
| Subject: | Biopharmaceutical industry | ESG performance | R&D partners | Stakeholder salience | Corporate Social Responsibility | Corporate social responsibility | Stakeholder | Biotechnologie-Industrie | Biotechnology industry | Pharmaindustrie | Pharmaceutical industry | Unternehmenserfolg | Firm performance | Nachhaltige Kapitalanlage | Sustainable investment | Welt | World | Performance-Messung | Performance measurement |
| Description of contents: | Description [doi.org] |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1016/j.jbusres.2025.115408 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10015432351